prednisone,niraparib,abiraterone
janssen
['gu ', 'brca', 'niraparib', 'crpc', 'pcsm', 'magnitude trial', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
adding niraparib to aap improved rpfs in patients with brca-mutated mcrpc in the phase 3 magnitude trial. presented at asco gu 2023. #gu23 #pcsm 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.